Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

For AYAs with Advanced Cancer, Study Finds Serious Communication Gaps about...

Ogkologos - 15 Απριλίου, 2025

Clinical Benefit of a Combination of Ipilimumab and Nivolumab in Treatment-Naïve...

Ogkologos - 15 Απριλίου, 2025

Similar Efficacy Between Subcutaneous and Intravenous Pembrolizumab Given with Chemotherapy for...

Ogkologos - 14 Απριλίου, 2025

FDA Approves Pembrolizumab for HER2 Positive Gastric or Gastro-oesophageal Junction Adenocarcinoma...

Ogkologos - 11 Απριλίου, 2025

Expanding Research on Dormant Cancer Cells Aims to Prevent Metastasis

Ogkologos - 10 Απριλίου, 2025

EMA Recommends Granting a Conditional Marketing Authorisation for Linvoseltamab

Ogkologos - 10 Απριλίου, 2025

Adding Pembrolizumab to Docetaxel Does Not Significantly Improve Outcomes in Patients...

Ogkologos - 9 Απριλίου, 2025

Adding One Year of Palbociclib to Adjuvant Endocrine Treatment Does Not...

Ogkologos - 8 Απριλίου, 2025

Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients...

Ogkologos - 7 Απριλίου, 2025

FDA Approves Vimseltinib for Symptomatic Tenosynovial Giant Cell Tumour

Ogkologos - 4 Απριλίου, 2025

1...525354...440 Σελίδα 53 από 440

MOST POPULAR

Teen Invents ‘Resilience Bra’ To Help Breast Cancer Patients With Post-Mastectomy...

13 Ιουνίου, 2019

How we are working with industry to translate research into real...

26 Απριλίου, 2022

Cómo aprendí a sobrellevar la culpa del superviviente después del cáncer

4 Μαΐου, 2022

Sacituzumab Govitecan Plus Pembrolizumab Demonstrate Encouraging Activity in Patients with mUC...

5 Φεβρουαρίου, 2024

Φόρτωση περισσοτέρων

For AYAs with Advanced Cancer, Study Finds Serious Communication Gaps about...

Clinical Benefit of a Combination of Ipilimumab and Nivolumab in Treatment-Naïve...

Similar Efficacy Between Subcutaneous and Intravenous Pembrolizumab Given with Chemotherapy for...

FDA Approves Pembrolizumab for HER2 Positive Gastric or Gastro-oesophageal Junction Adenocarcinoma...

Expanding Research on Dormant Cancer Cells Aims to Prevent Metastasis

EMA Recommends Granting a Conditional Marketing Authorisation for Linvoseltamab

Adding Pembrolizumab to Docetaxel Does Not Significantly Improve Outcomes in Patients...

Adding One Year of Palbociclib to Adjuvant Endocrine Treatment Does Not...

Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients...

FDA Approves Vimseltinib for Symptomatic Tenosynovial Giant Cell Tumour

MOST POPULAR

Teen Invents ‘Resilience Bra’ To Help Breast Cancer Patients With Post-Mastectomy...

How we are working with industry to translate research into real...

Cómo aprendí a sobrellevar la culpa del superviviente después del cáncer

Sacituzumab Govitecan Plus Pembrolizumab Demonstrate Encouraging Activity in Patients with mUC...

HOT NEWS

ESMO Calls on the European Commission to Fund Cancer Research and...

Coping with COVID: New Stimulus Funds and Unemployment Benefit Update

A Combination of Trifluridine-Tipiracil Plus Bevacizumab Results in Longer Overall Survival...

Darolutamide Maintenance Improves Outcomes in Patients with mCRPC Who Were Previously...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ